Santhera: Europe's CHMP Issues Positive Opinion For AGAMREE To Treat Duchenne Muscular Dystrophy
Swiss drug maker Santhera Pharmaceuticals Holding AG (SPHDF.OB) announced Friday that European Commission’s Committee for Medicinal Products for Human Use or CHMP adopted a positive opinion in favor of approval […]
» Read more